Immunologic approaches to various types of cancer with the use of BCG and purified protein derivatives.
D000230:Adenocarcinoma / Q000628:therapy; D000284:Administration, Oral; D001500:BCG Vaccine / Q000008:administration & dosage / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000628:therapy; D003429:Cross Reactions; D006801:Humans; D006968:Hypersensitivity, Delayed; D009163:Mycobacterium bovis / Q000276:immunology*; D009182:Mycosis Fungoides / Q000628:therapy; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D012878:Skin Neoplasms / Q000628:therapy; D014373:Tuberculin
D001500:BCG Vaccine; D014373:Tuberculin